Novago Therapeutics
NovaGo’s fully human monoclonal antibodies have the potential to become a safe and effective treatment in ophthalmology and central nervous system indications. NovaGo’s proprietary antibodies block t...load more
Novago Therapeutics's Basic Information
Industry
Headquarters
Switzerland
Founded Year
2015
Headcount
2 - 10 ( View All )
Specialties
Regenerative TherapyDiabetic RetinopathyOphthalmology
Frequently Asked Questions Regarding Novago Therapeutics
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts